Abstract

Human milk oligosaccharides (HMOs) comprise a group of structurally complex, unconjugated glycans that are highly abundant in human milk. HMOs are minimally digested in the gastrointestinal tract and reach the colon intact, where they shape the microbiota. A small fraction of HMOs is absorbed, reaches the systemic circulation, and is excreted in urine. HMOs can bind to cell surface receptors expressed on epithelial cells and cells of the immune system and thus modulate neonatal immunity in the infant gut, and possibly also sites throughout the body. In addition, they have been shown to act as soluble decoy receptors to block the attachment of various microbial pathogens to cells. This review summarizes the current knowledge of the effects HMOs can have on infections, allergies, auto-immune diseases and inflammation, and will focus on the role of HMOs in altering immune responses through binding to immune-related receptors.

Highlights

  • Immunological Effects of Human Milk OligosaccharidesReviewed by: Belinda van’t Land, University Medical Center Utrecht, Netherlands Gert Folkerts, Utrecht University, Netherlands

  • Based on its richness in immune-related components like human milk oligosaccharides (HMOs), milk proteins and lipids, breastmilk can be seen as the first functional food humans encounter during their life [1]

  • HMOs contribute to the development of the microbiota and the immune system of newborn infants

Read more

Summary

Immunological Effects of Human Milk Oligosaccharides

Reviewed by: Belinda van’t Land, University Medical Center Utrecht, Netherlands Gert Folkerts, Utrecht University, Netherlands. HMOs are minimally digested in the gastrointestinal tract and reach the colon intact, where they shape the microbiota. A small fraction of HMOs is absorbed, reaches the systemic circulation, and is excreted in urine. HMOs can bind to cell surface receptors expressed on epithelial cells and cells of the immune system and modulate neonatal immunity in the infant gut, and possibly sites throughout the body. They have been shown to act as soluble decoy receptors to block the attachment of various microbial pathogens to cells.

INTRODUCTION
HMO ABSORPTION
Potential HMO Receptors
An overview of putative receptors for HMO is shown in
Known HMO ligands
Antigen presenting cells
Observational study Observational pilot study
Observational study
Study setup
Effects on Bacterial Adhesion and Infection
Effects on Intestinal Viruses
Effects on Respiratory Viruses
Effects of HMOs on Intestinal Epithelium
Effects of HMOs on Immune Function
HMOs AND ALLERGY
CONCLUSIONS
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call